Form D · Biotechnology

Vesselon, Inc.

Norwalk, CT · CIK 0001613009

Offering snapshot reported Aug 22, 2016 · SEC filing

Reported sold
$250K
Offering amount: $1M
Investors reported
3
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Mar 17, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$125K$250KJul 5, 2016: $150,000.00Jul 5, 2016Aug 22, 2016: $250,000.00Aug 22, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$150,000 → $250,000
  • Reported investors1 → 3
  • Minimum accepted$150,000 → $25,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 22, 2016Amendment$250,000$100,000vs Jul 5, 20163SEC filing
Jul 5, 2016Initial$150,000No comparison1SEC filing
Jul 5, 2016Initial$75,000No comparison1SEC filing
Jun 11, 2015Initial$1,000,000No comparison11SEC filing
Jul 18, 2014Initial$100,000No comparison1SEC filing

Offering details

Securities
Equity, Debt, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-266331
Senior promissory notes convertible into equity securities of the Issuer.

Source: Form D, filed Aug 22, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kevin Kimberlin Director
Clayton T Larsen Director, Executive
Clay Larsen Director, Executive
Paul Latchford Director
Paul S. Latchford, Jr. Director
Rhodemann Li Director, Executive
Jurgen Raths Director
Jon Serbousek Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
101 Merritt 7 Suite 300
Norwalk, CT, 06851